Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non Operating Income: 2016-2025

Historic Non Operating Income for Viridian Therapeutics, Inc.\DE (VRDN) over the last 10 years, with Sep 2025 value amounting to $5.4 million.

  • Viridian Therapeutics, Inc.\DE's Non Operating Income fell 20.28% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year increase of 0.73%. This contributed to the annual value of $29.1 million for FY2024, which is 74.00% up from last year.
  • Viridian Therapeutics, Inc.\DE's Non Operating Income amounted to $5.4 million in Q3 2025, which was down 10.25% from $6.0 million recorded in Q2 2025.
  • Viridian Therapeutics, Inc.\DE's Non Operating Income's 5-year high stood at $7.7 million during Q4 2024, with a 5-year trough of $34,000 in Q2 2021.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Non Operating Income averaged around $5.8 million, with its median value being $6.0 million (2025).
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Non Operating Income slumped by 42.11% in 2021, and later spiked by 5,669.86% in 2023.
  • Quarterly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Non Operating Income stood at $135,000 in 2021, then soared by 2,330.37% to $3.3 million in 2022, then spiked by 40.75% to $4.6 million in 2023, then skyrocketed by 67.76% to $7.7 million in 2024, then dropped by 20.28% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $6.0 million for Q2 2025, and $7.0 million during Q1 2025.